Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells.
第一作者:
Naseer,Maliyakkal
第一单位:
Department of Basic Medical Sciences, College of Applied Medical Sciences in Khamis Mushait, King Khalid University, Abha, Saudi Arabia.;Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.;Cancer Research Unit, King Khalid University, Abha, Saudi Arabia.
作者:
关键词
ABC, ATP-binding cassetteANOVA, Analysis of varianceActive drug targetingBBB, Blood brain barrierBCRP, Breast cancer resistance proteinCSP, CisplatinCSP-NPs, Cisplatin nanoparticles DMEM, Dulbecco’s modified eagle mediumCisplatin nanoparticlesDMSO, Dimethyl sulfoxideDNR, DaunorubicinDOX, DoxorubicinDrug uptake and accumulationsEDTA, Ethylenediaminetetraacetic acidEPR, Enhanced permeability retentionFACS, Fluorescence activated cell sortingFBS, Fetal bovine serumFTC, Fumitremorgin CGBM, Glioblastoma multiformeHBSS, Hank’s balanced salt solutionHPLC, High Performance Liquid ChromatographyInduction of ApoptosisMDR, Multidrug resistanceMTT, Methyl tetrazoliumMX, MitoxantroneNPs, NanoparticlesO.D., Optical densityPBS, Phosphate buffer salinePI, Propidium iodidePLGA, Poly (lactic-co-glycolic) acidRT, Room temperatureRho-123, Rhodamine 123SDS, Sodium dodecyl sulfateSEM, Scanning electron microscopyTargeting multidrug resistance (MDR) transportersnm, Nanometer
DOI
10.1016/j.jsps.2021.07.001
PMID
34408546
发布时间
2022-04-25
- 浏览2

Saudi pharmaceutical journal
2021年29卷8期
857-873页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文